Template:Hyperlipoproteinemia: Difference between revisions

	Hyperlipoproteinemia Microchapters
Lipid Disorders Main Page
Hyperlipoproteinemia Main Page
Patient Information
Overview
Classification
Synopsis
Differential Diagnosis
Diagnostic Algorithm
Screening
Primary Hyperlipoprotein Disorders:
Type I - Familial hyperchylomicronemia
Type II
Type IIA - Familial hypercholesterolemia
Type IIB - Familial combined hyperlipidemia
Type III - Dysbetalipoproteinemia
Type IV - Primary hypertriglyceridemia
Type V - Mixed hyperlipoproteinemia
ACC/AHA Guideline Recommendations
Summary
Treatment
Major recommendations for statin therapy
Therapeutic response to statin therapy
Blood cholesterol LDL and non-HDL treatment goals
Treatment in heart failure and hemodialysis
Primary prevention
Secondary prevention
Intensity of statin therapy in primary and secondary prevention
Safety Recommendations
Guideline on Lifestyle Management

VisualWikitext

@@ Line 108: / Line 108: @@
 |-
 !
+|- bgcolor="CadetBlue"
+!
+'''ACC/AHA Guideline Recommendations'''
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[ACC AHA guideline on summary of Key Recommendations for the Treatment of Blood Cholesterol to Reduce ASCVD Risk in Adults|Summary]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[ACC AHA guideline on the treatment of blood cholesterol|Treatment]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[ACC AHA guideline on the treatment of blood cholesterol statin treatment|Major recommendations for statin therapy]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy|Therapeutic response to statin therapy]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[ACC AHA guideline on the treatment of blood cholesterol LDL and non-HDL treatment goals|Blood cholesterol LDL and non-HDL treatment goals]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[ACC AHA guideline on the treatment of blood cholesterol heart failure and hemodialysis|Treatment in heart failure and hemodialysis]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[ACC AHA guideline on the treatment of blood cholesterol primary prevention|Primary prevention]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[ACC AHA guideline on the treatment of blood cholesterol secondary prevention|Secondary prevention]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[ACC AHA guideline on the treatment of blood cholesterol intensity of statin therapy in primary and secondary prevention|Intensity of statin therapy in primary and secondary prevention]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[ACC AHA guideline on the treatment of blood cholesterol safety|Safety Recommendations]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[Lifestyle Management to Reduce Cholestrol|Guideline on Lifestyle Management]]
+|-
+!
 |}

Template:Hyperlipoproteinemia: Difference between revisions

Revision as of 21:30, 23 November 2016

Navigation menu